Izrael in Pfizer sta za srčne zaplete vedela mesece pred javnostjo

Povzetek članka na temo vpliva cepiva proti Covid-19 na srce

Članek organizacije Children’s Health Defense z naslovom „Israel, Pfizer Knew COVID Vaccine Caused Fatal Heart Condition — But Waited Months Before Alerting Public“, objavljen 14. septembra 2026, povzema novo recenzirano študijo, objavljeno v reviji EXCLI Journal. Avtor članka je Michael Nevradakis, Ph.D.

Osrednja trditev članka je, da sta izraelsko ministrstvo za zdravje (MOH) in Pfizer že v začetku leta 2021 razpolagala z informacijami o pomembnem varnostnem signalu, povezanem s srčnimi dogodki po cepljenju s Pfizerjevim cepivom proti Covid-19, vendar naj bi bile te informacije zdravnikom in javnosti posredovane šele z večmesečnim zamikom.

Podatki iz izraelskega registra

Raziskovalci so pregledali podatkovni niz izraelskega ministrstva za zdravje, ki je vseboval 531 zapisov hospitalizacij iz obdobja od marca 2021 do maja 2022. V podatkovnem nizu je bilo tudi 67 smrti, od tega devet pri osebah, mlajših od 50 let. Dve od teh devetih smrti sta bili pripisani miokarditisu.

Časovna povezava

Po članku je pomembna ugotovitev študije, da so številni zapisi pri mlajših bolnikih opisovali pojav akutnega vnetja srca v dneh do tednih po cepljenju. Članek poudarja, da so bile v poročilih vključene tudi številne mlajše osebe in posamezniki brez predhodne zdravstvene anamneze.

Podatki niso zajemali samo srčnih težav. Raziskovalci so našli tudi zapise o aritmijah, omedlevicah, srčnem popuščanju, epileptičnih napadih, možganski kapi, encefalitisu, Guillain-Barréjevem sindromu, paralizah lobanjskih živcev, sumu na anafilaksijo, multisistemskem vnetnem sindromu, imunski trombocitopeniji, akutni poškodbi ledvic in nenadni izgubi sluha.

Zamuda pri javnem obveščanju

Članek nato opisuje časovnico.

  • Januarja 2021 so bili v Izraelu zaznani prvi primeri miokarditisa.
  • Februarja 2021 je Izrael ameriškemu CDC in drugim zdravstvenim oblastem posredoval informacije o približno 40 primerih miokarditisa.
  • V začetku marca 2021 je bil CDC opozorjen na „large numbers“ primerov miokarditisa in perikarditisa pri mladih v Izraelu.
  • Aprila 2021 sta CDC in FDA zanikala obstoj varnostnega signala za miokarditis.
  • Maja 2021 je CDC zdravnikom izdal priporočilo, naj poročajo o vseh primerih miokarditisa ali perikarditisa.
  • Informacije o približno 40 izraelskih primerih, posredovane CDC februarja 2021, so po članku postale javne šele februarja 2023, po zahtevi FOIA, ki jo je vložil CHD.

Avtorji študije menijo, da bi lahko takšno zamujanje vplivalo na klinično prepoznavanje tveganja in informirano odločanje pacientov.

Bistvo članka v enem stavku

Članek trdi, da nova analiza izraelskih zdravstvenih podatkov kaže, da so bili primeri miokarditisa, perikarditisa, drugih resnih zdravstvenih dogodkov in tudi smrti pri delu cepljenih zabeleženi kmalu po cepljenju, da so bili podatki posredovani Pfizerju in zdravstvenim oblastem, vendar je bilo javno obveščanje o varnostnem signalu po navedbah avtorjev več mesecev zamaknjeno.

Celoten članek

Članek hranimo v celoti, da ostane dosegljiv, če povezava kdaj odpove. The Defender ponatis dovoljuje pod licenco Creative Commons CC BY-NC-ND 4.0, ki pa prepoveduje predelavo. Zato je članek tu v izvirni angleščini, nespremenjen in z vsemi povezavami. Prevod bi bil predelava, zato ga ni. Slik nismo prevzeli, ker za njih ne dajo pravic.

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website.

Israel, Pfizer Knew COVID Vaccine Caused Fatal Heart Condition — But Waited Months Before Alerting Public

The authors of a peer-reviewed study published last week in EXCLI Journal concluded that Pfizer and Israel’s Ministry of Health knew in early 2021 about a significant “cardiac event” safety signal associated with Pfizer’s COVID-19 vaccine — but withheld the information from physicians and the public for several months. A significant number of Israeli government reports involving younger patients recorded the onset of “acute cardiac inflammation” within “days to weeks of vaccination.”

Michael Nevradakis, Ph.D., The Defender
September 14, 2026

Pfizer and Israel’s Ministry of Health (MOH) knew in early 2021 about a significant “cardiac event” safety signal associated with Pfizer’s COVID-19 vaccine — but withheld the information from physicians and the public for several months, a new peer-reviewed study has found.

The authors of the study, published last week in EXCLI Journal, reviewed an MOH dataset containing 531 hospitalization records dating from March 2021 — just months after the rollout of the mRNA Pfizer-BioNTech shot — to May 2022.

The records included 67 deaths, including nine in patients under age 50. Two of the nine deaths were attributed to myocarditis, which can lead to cardiac arrhythmia and death.

Myocarditis was recorded in 71.6% of the hospitalization records involving patients under 30. Nearly two-thirds of those patients “had no meaningful medical history” before their diagnosis.

The deaths and injuries were reported to Israel’s MOH and to Pfizer. Yet, public health authorities in Israel, the U.S. and elsewhere downplayed the safety signal, reporting it “only after a delay of approximately three to four months.”

Even then, health authorities described most cases as “rare” or “mild” — and of less concern than the risk COVID-19 posed.

Karl Jablonowski, Ph.D., senior research scientist for Children’s Health Defense (CHD), said none of the myocarditis deaths are found in the U.S. government’s Vaccine Adverse Event Reporting System (VAERS), even though Pfizer was obligated to report the deaths to VAERS.

“The bereaved and the injured are owed an answer,” Jablonowski said.

Steve Kirsch, founder of the Vaccine Safety Research Foundation, said the study’s findings are significant because they are based on “internal government data” instead of data from vaccine makers or from publicly available databases.

Kirsch said the data show that Israel’s MOH “was clearly more interested in protecting the manufacturers than the public.”

Dr. Jane Orient, executive director of the Association of American Physicians and Surgeons, said the findings reflect a trend across multiple countries, in which public health authorities and Big Pharma hid the risks of the COVID-19 shots.

“I don’t think Israel is an outlier. Pharmaceutical companies, public health authorities, organized medicine, and academics worldwide have performed shamefully and betrayed our trust,” Orient said.

‘Generally short intervals’ between vaccination and injuries, deaths

The study presents a breakdown of the 531 hospitalization records and 67 death records in the Israeli MOH data, noting that these cases involved a significant number of younger patients. These cases were reported to Pfizer in 2021 and 2022.

“Reported events spanned cardiac, neurological, inflammatory, and other serious clinical categories and involved a substantial proportion of younger individuals, with 211 of 530 hospitalization records with valid age data (39.8 %) involving patients under 30 years of age,” the study states.

Other key findings from the study include:

  • The two myocarditis-related deaths in people under 50 involved a 22-year-old woman and a 47-year-old man.
  • An additional death of a younger adult — a 35-year-old man — was also identified. His record indicated “worsening heart failure” but did not mention myocarditis.
  • Μyocarditis or pericarditis was identified in 250 of 531 hospitalization records (47.1%) and in 151 of 211 records (71.6%) of patients under 30.
  • 48 patients under 18 were diagnosed with myocarditis or pericarditis.
  • 134 of the 211 patients under 30 had “no meaningful medical history,” of which 99 of 134 were diagnosed with myocarditis and pericarditis — most of whom were male (90 out of the 99, or 90.9%).

According to the study, a significant number of records involving younger patients recorded the onset of “acute cardiac inflammation” that developed “within days to weeks of vaccination.”

Though the study focused on myocarditis and pericarditis, the researchers’ review of the records also identified a “broad spectrum” of other “serious clinical events.” These injuries included:

The combination of detailed case-level clinical documentation, the “generally short intervals” between vaccination and injury, the formal reporting to Pfizer and the fact that the data were sourced from a government health authority support the study’s credibility, the authors said.

Pfizer was kept in loop about deaths in 2021-2022

Israel MOH records also showed Pfizer was kept in the loop about the deaths and hospitalizations, receiving nine such reports between March 2021 and May 2022.

The first report, dated March 25, 2021, included information on 157 hospitalizations and 46 deaths.

“Reports to Pfizer, which began no later than March 25, 2021, included a notable proportion of young individuals, including many for whom no meaningful medical history was identified,” the study states.

Yet, Pfizer — and public health authorities worldwide — sat on this information for weeks or months before revealing it to the public.

The study cited documentary evidence of these delays — and the subsequent downplaying of the severity of the serious adverse events related to the vaccine.

For instance, an October 2021 New England Journal of Medicine study found that early myocarditis cases were detected in Israel as early as January 2021 — only a month after the Pfizer-BioNTech vaccine was released to the public.

On Feb. 28, 2021, Israel alerted the Centers for Disease Control and Prevention (CDC) and other public health authorities about approximately 40 myocarditis cases.

But this information didn’t become public until February 2023, following a Freedom of Information Act (FOIA) request that CHD submitted to the CDC.

In early March 2021, the CDC was warned about “large numbers” of myocarditis and pericarditis cases among young people in Israel.

A week later, officials from the CDC and U.S. Food and Drug Administration (FDA) circulated an internal response about the myocarditis cases reported in Israel, stating that no additional details about those cases were available.

Yet on April 26, 2021, the CDC and FDA denied that “safety signals” existed for myocarditis. It wasn’t until May 28, 2021, that the CDC issued a recommendation to all clinicians to report “all cases” of myocarditis or pericarditis.

The authors of the EXCLI Journal study suggested that the decision by public health authorities and Pfizer to sit on this information “may have had implications for clinical awareness and informed decision-making.”

Epidemiologist M. Nathaniel Mead, Ph.D., a McCullough Foundation scholar, agreed. “Informed consent should have included an age-and-sex-specific warning in time for them to say no, delay a second dose, or choose differently. Many men never got that chance.”

Were more vaccine-related deaths concealed?

The study found that the dataset provided by Israel’s MOH appeared to have been revised several times, noting that later versions “added clinical information to existing records, revised diagnoses and reporting dates, and omitted some records.”

The omissions included a death report contained in an October 2021 version of the MOH’s dataset that was “no longer present in the December or any subsequent version.”

According to the study, the dataset contains no “methodological documentation” and “no formal audit trail identifying who made these changes or the reasons for them,” making it impossible to tell why these revisions were made based on the available data.

Later revelations show Israeli authorities continued to downplay the risks of the COVID-19 shot well into 2022. A leaked video from June 2022 revealed that researchers shared data with Israel’s MOH showing serious and long-term side effects linked to the Pfizer-BioNTech shot.

The video suggested that Israel’s MOH did not reveal this information to the expert committee that met later that month to decide on recommending the vaccine for children under age 5, or to leaders of Israel’s COVID-19 vaccine booster program.

Kirsch said the delayed public release of the data and the open questions that remain about how the data were entered and updated raise accountability concerns that span beyond Israel’s MOH and Pfizer to include the broader medical community.

“Nobody was fired. More importantly, no pro-vaccine doctor in the U.S. has expressed any outrage in the suppression of the Israeli safety data,” Kirsch said.

Orient said the study adds to evidence supporting the suspension and withdrawal of mRNA vaccines from the marketplace.

“There is no justification for the continued use of these vaccines. There should be no further iterations unless and until all questions are answered and benefit is shown to exceed risk — if ever. We should instead be concentrating on treatment.”

Related articles in The Defender

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

Priloge in viri

Avtor: Društvo S33